Publications by authors named "Rebecca Wayte"

Claim this Profile
R
Real-world Australian experience with tisagenlecleucel for relapsed/refractory diffuse large B-cell lymphoma-importance of pre-CAR-T optimization.
Phoebe Joy Ho, Vinay Vanguru, Cale S Burge, Rebecca Wayte, Christina Brown

Front Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Insights of Post-Infusion CAR T Expansion and Persistence for Large B-Cell Lymphoma.
Grace Wolyncewicz, Rebecca Wayte, Edward Abadir

Cancers (Basel)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced Chimeric Antigen Receptor T Cell Expansion Postinfusion Is Associated with Poor Survival in Patients with Large B Cell Lymphoma after Two or More Therapies.
Edward Abadir, Rebecca Wayte, Wenlong Li, Sachin Gupta, Shihong Yang

Transplant Cell Ther· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ANZTCT practice statement: sinusoidal obstruction syndrome/veno-occlusive disease diagnosis and management.
Shaun Fleming, Ashleigh P Scott, John Coutsouvelis, Chris Fraser, Ashish Bajel, Rebecca Wayte

Intern Med J· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association of mobilising regimen on immune reconstitution and survival in myeloma patients treated with bortezomib, cyclophosphamide and dexamethasone induction followed by a melphalan autograft.
Matthew J Rees, Peter Mollee, Jun Yen Ng, Alex Murton, Jose Filipe Gonsalves, Rebecca Wayte

Bone Marrow Transplant· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis